Some extended-release formulations of the diabetes drug metformin contained levels of a nitrosamine impurity falling above the US Food and Drug Administration’s (FDA’s) acceptable intake limit, ...
Two manufacturers have announced voluntary recalls of metformin formulations containing elevated levels of a potential carcinogen. Granules Pharmaceuticals, based in Virginia, has issued a recall for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results